No abstract available
Keywords:
drug delivery; molecular imaging; multimodality; nanomedicine; nuclear medicine; radiolabeled nanomaterials; radionuclide therapy; radiopharmaceuticals.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work has been supported in part by a grant from the French National Agency for Research called Investissements d'Avenir Labex IRON No. ANR-11-LABX-0018-01.